PIK3CA and breast cancer: Regarding gene alterations as well as the upregulation of ABL-1 in BM and downregulation of PIK3CA in metastatic breast cancer cells, BRAF mutations in melanoma and EGFR and KRAS overexpressions in lung cancer have been reported [90, 92, 104, 105].